Advertisements



We are Sorry, This Page doesn't Exist


Wednesday’s Vital Data: Valeant Pharmaceuticals Intl Inc (VRX), Walt Disney Co (DIS) and Citigroup Inc (C)

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Valeant (VRX) and Disney (.....»»

Category: topSource: investorplaceMay 9th, 2018

Valeant Pharmaceuticals Intl Inc Has New Name But Same Problems

InvestorPlace - Stock Market News, Stock Advic.....»»

Category: topSource: investorplaceJun 9th, 2018

Valeant Pharmaceuticals Intl Inc Shares Sink on Psoriasis Treatment Rejection by FDA

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Valean.....»»

Category: topSource: investorplaceJun 19th, 2018

Valeant Posts Q1 Earnings Beat, Announces Name Change To Bausch Health

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares were surging nearly 14 percent after the open Tuesday after the company reported first-quarter results and announced a name change to Bausch Health Companies Inc. read more.....»»

Category: blogSource: benzingaMay 8th, 2018

Valeant Posts Q1 Earnings Beat, Announces Name Change To Bausch Health

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares were.....»»

Category: earningsSource: benzingaMay 8th, 2018

Why Valeant Pharmaceuticals International Stock Is Moving Higher Today

The pace of Valeant's turnaround may be picking up......»»

Category: topSource: foxnewsMay 8th, 2018

Bausch Health Insiders Are Stepping Up Their Stock Buys

Three executives at the former Valeant Pharmaceuticals have bought $5.1 million in shares so far this year......»»

Category: topSource: barronsSep 22nd, 2018

Insider Weekends: 3 Insiders Of The Company Formerly Known As Valeant Pharmaceuticals Buy Stock

Insider Weekends: 3 Insiders Of The Company Formerly Known As Valeant Pharmaceuticals Buy Stock.....»»

Category: topSource: seekingalphaSep 25th, 2018

Here"s How Much You Would Have Made Owning Johnson Controls Intl Stock In The Last 15 Years

read more.....»»

Category: blogSource: benzingaMay 24th, 2024

Here"s How Much You Would Have Made Owning Marriott Intl Stock In The Last 20 Years

read more.....»»

Category: blogSource: benzingaMay 17th, 2024

Recursion Pharmaceuticals Stock Surges 10% As Nvidia-Powered Supercomputer Completion Sparks Investor Optimism

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) made waves Monday afternoon not only with the announcement of its groundbreaking BioHive-2 supercomputer but also with a notable surge in its stock performance. read more.....»»

Category: blogSource: benzingaMay 13th, 2024

Why Is Small-Cap Alzheimer"s-Focused AC Immune Stock Trading Higher On Monday?

Unlocking hope for Alzheimer's with ACI-24.060. Takeda's agreement with AC Immune targets toxic forms of Abeta, potentially slowing disease progression. read more.....»»

Category: blogSource: benzingaMay 13th, 2024

Nvidia-Backed Recursion Pharmaceuticals Stock Is Up On Q1 Earnings: Everything You Need To Know

Recurs.....»»

Category: blogSource: benzingaMay 9th, 2024

Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?

EyePoint Pharmaceuticals reveals Phase 2 PAVIA trial results for Duravyu in non-proliferative diabetic retinopathy. Positive data showcases Duravyu's efficacy and safety profile. read more.....»»

Category: blogSource: benzingaMay 6th, 2024

Why Is NRx Pharmaceuticals Stock Falling After Data From Suicidal Bipolar Depression Study

NRX Pharmaceuticals announces Phase 2b/3 trial findings of NRX-101 vs. Lurasidone for Suicidal Bipolar Depression. read more.....»»

Category: blogSource: benzingaApr 30th, 2024

Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends

Incyte acquires Escient Pharmaceuticals for $750 million, bolstering its pipeline. Cantor Fitzgerald initiates coverage with a Neutral rating, citing undervaluation concerns despite strong cash flow. Latest Ratings for INCY DateFirmActio.....»»

Category: blogSource: benzingaApr 23rd, 2024

Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors" Radars Today

On Wednesday, key U.S. stock indexes closed lower, as the Dow Jones I.....»»

Category: blogSource: benzingaApr 10th, 2024

Pieris stock rockets on record volume after Genentech collaboration valued at up to $1.4 billion

Shares of Pieris Pharmaceuticals Inc. rocketed 57.3% on massive volume in afternoon trading Tuesday, after the Boston-based biotechnology company announced a respiratory and ophthalmology collaboration with Roche Holding AG's .....»»

Category: topSource: marketwatchMay 25th, 2021

What"s Going On With Pieris Pharmaceuticals Stock Today?

Pieris Pharmaceuticals Inc (NASDAQ: PIRS) shares are trading higher by 57% at $2.91 after the company announced a respiratory and ophthalmology collaboration with Genentech. read more.....»»

Category: blogSource: benzingaMay 25th, 2021

Anebulo Pharmaceuticals started at buy with $15 stock price target at Benchmark

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 25th, 2021